Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN955390 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tubulin, beta 1 (TUBB1) (AA 11-39), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term, AA 11-39
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders.
Human mutations that confer paclitaxel resistance.
Roles of beta-tubulin residues Ala428 and Thr429 in microtubule formation in vivo.
Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of beta-tubulin at Cys 12 and suppression of microtubule dynamics.
Antón AI, González-Conejero R, Roldán V, Quiroga T, Sánchez-Vega B, Corral J, Vicente V, Mezzano D
Annals of hematology 2010 Nov;89(11):1147-54
Annals of hematology 2010 Nov;89(11):1147-54
Human mutations that confer paclitaxel resistance.
Yin S, Bhattacharya R, Cabral F
Molecular cancer therapeutics 2010 Feb;9(2):327-35
Molecular cancer therapeutics 2010 Feb;9(2):327-35
Roles of beta-tubulin residues Ala428 and Thr429 in microtubule formation in vivo.
Joe PA, Banerjee A, Ludueña RF
The Journal of biological chemistry 2009 Feb 13;284(7):4283-91
The Journal of biological chemistry 2009 Feb 13;284(7):4283-91
Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of beta-tubulin at Cys 12 and suppression of microtubule dynamics.
Xu W, Xi B, Wu J, An H, Zhu J, Abassi Y, Feinstein SC, Gaylord M, Geng B, Yan H, Fan W, Sui M, Wang X, Xu X
Molecular cancer therapeutics 2009 Dec;8(12):3318-30
Molecular cancer therapeutics 2009 Dec;8(12):3318-30
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
